Insider · CIK 0001553150

Walker Paul Edward

Reports to the SEC for 18 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001553150

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-10	KRROKorro Bio, Inc.P Purchase	10% Owner	PPurchase	+207K sh	$11.11	+$2.3M	1,297,893
2026-03-10	KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase	10% Owner	PPurchase	+243K sh	$11.11	+$2.7M	242,945
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.62M sh	—	—	1,619,240
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.37M sh	—	—	2,989,408
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.37M sh	—	—	4,359,576
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+738K sh	—	—	5,097,538
2026-02-09	SGPSpyGlass Pharma, Inc.P Purchase	10% Owner	PPurchase	+938K sh	$16.00	+$15M	6,035,038
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+955K sh	—	—	954,990
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+402K sh	—	—	1,357,263
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.62M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion	10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion	10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−738K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−955K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−402K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+189K sh	$0.01	+$1,891.95	788,259
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−280 sh	$6.75	−$1,890	787,979
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+372K sh	$0.01	+$3,722.55	1,160,234
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−551 sh	$6.75	−$3,719.25	1,159,683
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1.16M sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+189K sh	$0.01	+$1,891.95	488,982
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−280 sh	$6.75	−$1,890	488,702
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+186K sh	$0.01	+$1,861.28	674,830
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−276 sh	$6.75	−$1,863	674,554
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−675K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+1.66M sh	$0.01	+$16.6K	1,656,789
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−2,455 sh	$6.75	−$16.6K	1,654,334
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+608K sh	$0.01	+$6,075.36	2,261,870
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−900 sh	$6.75	−$6,075	2,260,970
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+124K sh	$0.01	+$1,240.85	2,385,055
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−182 sh	$6.75	−$1,228.5	2,384,873
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2.38M sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−189K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+372K sh	—	—	372,255
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−372K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−189K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+186K sh	—	—	186,128
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−186K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−75K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−37.7K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−1.66M sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−608K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+124K sh	—	—	124,085
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−124K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−125K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−100K sh	—	—	0
2025-05-15	Allakos Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2.76M sh	—	—	0
2025-05-15	Allakos Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3.39M sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.6K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0

Recent filings

Accepted (ET)
Mar 124
Walker Paul Edward0001193125-26-104714
SEC(opens sec.gov)
Feb 135
Walker Paul Edward0001193125-26-051520
SEC(opens sec.gov)
Feb 114
Walker Paul Edward0001193125-26-046662
SEC(opens sec.gov)
Oct 64
Walker Paul Edward0001193125-25-232143
SEC(opens sec.gov)

Companies

Address

2855 SAND HILL ROAD

MENLO PARK, CA, 94025